argenx is seeking a Senior Director, Patient Marketing & Commercial Strategy MMN-CIDP Franchise in Boston to lead the growth of Vyvgart Hytrulo in CIDP and guide the upcoming Empa launch in MMN and CIDP. The role requires steering cross-functional teams, optimizing omnichannel strategies, and shaping the franchise value story.
The position demands 12-15+ years in biopharma commercial roles, launch experience, and a track record of multi-asset portfolio leadership, with an MBA or advanced degree
#J-18808-Ljbffr
Senior Director, Dual-Asset Patient Marketing Strategy
argenx · Boston, MA, USA ·
- Job type:
- Full Time
About argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx’s first experimental medicine, efgartigimod, is being evaluated in multiple autoimmune diseases, including myasthenia gravis (MG), pemphigus vulgaris (PV), immune thrombocytopenia (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP).
argenx is located in Ghent, Belgium, Boston, Massachusetts and Tokyo, Japan.